Submissions from 2020
Incidence and outcomes of heparin-induced thrombocytopenia in solid malignancy: an analysis of the National Inpatient Sample Database, Rohit Kumar, Shruti Bhandari, Sukhpreet RK Singh, Sindhu Malapati, and Kamila I. Cisak
Poroid Hidradenoma; a Benign Lesion Masking as Malignant Breast Tumor, Hassan Liaqat, Mohammad Ammad Ud Din, and Devin Malik
Real-world effectiveness of the pegfilgrastim on-body injector in preventing severe neutropenia, Lucas G. Maahs, Amy Tang, Zaid Al-Saheli, Brigid Jacob, Rishika Polasani, and Clara Hwang
Atezolizumab Versus Docetaxel in Pretreated Patients With NSCLC: Final Results From the Randomized Phase 2 POPLAR and Phase 3 OAK Clinical Trials, Julien Mazieres, Achim Rittmeyer, Shirish M. Gadgeel, Toyoaki Hida, David R. Gandara, Diego L. Cortinovis, Fabrice Barlesi, Wei Yu, Christina Matheny, Marcus Ballinger, and Keunchil Park
Outcomes According to ALK Status Determined by Central Immunohistochemistry or Fluorescence In Situ Hybridization in Patients With ALK-Positive NSCLC Enrolled in the Phase 3 ALEX Study, Tony Mok, Solange Peters, D. Ross Camidge, Johannes Noé, Shirish M. Gadgeel, Sai-Hong I. Ou, Dong-Wan Kim, Krzysztof Konopa, Emanuela Pozzi, Ting Liu, Isabell R. Loftin, Crystal Williams, and Alice T. Shaw
Bilateral breast masses as a presentation for T-cell acute lymphoblastic leukaemia, Osama Mosalem, Fawzi Abu Rous, Ahmed Elshafie, and Daniel Isaac
Pulmonary embolism as the primary presentation of IgA vasculitis, Osama Mosalem, Nora Hernandez Garcilazo, Yehia Saleh, and Fawzi Abu Rous
A user's guide to lorlatinib, Misako Nagasaka, Yubin Ge, Ammar Sukari, Geetika Kukreja, and Sai-Hong Ignatius Ou
Predictors of response and outcome of patients with acquired haemophilia A, Ifeoma Onwubiko, Gary Kasperek, Rosarina A. Laforest, Samuel G. Philip, Philip Kuriakose, and Zaher K. Otrock
Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection, Neha R. Patil, Erica S. Herc, and Marian R. Girgis
Exceptional Response to A Single Cycle of Immunotherapy in a Lynch Syndrome Patient with Metastatic Pancreatic Adenocarcinoma, Neha R. Patil and Gazala N. Khan
Primary Pleural Extranodal Marginal Zone Lymphoma Presenting as Bilateral Chylothorax, Thushara Paul, Dhiraj K. Yadav, Mohamed Alhamar, and Vrushali Dabak
Molecular therapeutic targets in non-small cell lung cancer, Kamya Sankar, Shirish M. Gadgeel, and Angel Qin
A Versatile Chemoenzymatic Synthesis for the Discovery of Potent Cryptophycin Analogs, Jennifer J Schmidt, Yogan Khatri, Scott I Brody, Catherine Zhu, Halina Pietraszkiewicz, Frederick A. Valeriote, and David H. Sherman
Toxicity in combination immune checkpoint inhibitor and radiation therapy: a systematic review and meta-analysis, Congzhou M Sha, Eric J. Lehrer, Clara Hwang, Daniel M. Trifiletti, Heath B. Mackley, Joseph J. Drabick, and Nicholas G. Zaorsky
Desperate times, desperate measures: successful use of chemotherapy in treatment of haemophagocytic lymphohistiocytosis (HLH) due to disseminated histoplasmosis, Sunny RK Singh, Kannan Thanikachalam, and Vijayalakshmi Donthireddy
COVID-19 and Cancer: Lessons Learnt from a Michigan Hotspot, Sunny RK Singh, Kannan Thanikachalam, Hiba Jabbour Aida, Laila M. Poisson, and Gazala Khan
Pseudo-Thrombocytosis Caused by Extreme Microcytosis in a Patient with Alpha Thalassemia Trait, Alexander A. Slota, Devin Malik, and Diane Hall
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant, Scott R. Solomon, Andrew St. Martin, Mei-Jie Zhang, Karen Ballen, Asad Bashey, Minoo Battiwalla, Lee Ann Baxter-Lowe, Claudio Brunstein, Saurabh Chhabra, Miguel Perez, Ephraim J. Fuchs, Siddhartha Ganguly, Nancy Hardy, Peiman Hematti, Joseph McGuirk, Edward Peres, Olle Ringden, David Rizzieri, Rizwan Romee, Melhem Solh, David Szwajcer, Marjolein van der Poel, Edmund Waller, Basem M. William, and Mary Eapen
Brief Report: Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination with Pegilodecakin in Patients with Metastatic Non-Small-Cell Lung Cancer (CYPRESS-1 and CYPRESS-2), David Spigel, Robert Jotte, John Nemunaitis, Merrill Shum, Jeffrey Schneider, Jerome Goldschmidt, Jennifer Eisenstein, David Berz, Lasika Seneviratne, Matei Socoteanu, Viralkumar Bhanderi, Kartik Konduri, Meng Xia, Hong Wang, Rebecca R Hozak, Ivelina Gueorguieva, David Ferry, Leena Gandhi, Bo H Chao, and Igor Rybkin
The role of immune checkpoint inhibitors in anaplastic thyroid cancer (Case Series), Ammar Sukari, Geetika Kukreja, Misako Nagasaka, Mohammad K. Shukairy, George Yoo, Ho-Sheng Lin, Jeffrey Hotaling, and Harold Kim
Disparities in the Uptake of Telemedicine During the COVID-19 Surge in a Multidisciplinary Head and Neck Cancer Population by Patient Demographic Characteristics and Socioeconomic Status, Samantha Tam, Vivian Wu, Amy M. Williams, Marian R. Girgis, Jawad Z. Sheqwara, Farzan Siddiqui, and Steven S. Chang
Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer, Kannan Thanikachalam, Vijay Damarla, Trevor Seixas, Irina Dobrosotskaya, Ira Wollner, David Kwon, Kenneth Winters, Mohammad Raoufi, Jia Li, Farzan Siddiqui, and Gazala Khan
Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study, Claire F. Verschraegen, Guy Jerusalem, Edward F. McClay, Nicholas Iannotti, Charles H. Redfern, Jaafar Bennouna, Franklin L. Chen, Karen Kelly, Janice Mehnert, John C. Morris, Matthew Taylor, David Spigel, Ding Wang, Hans Juergen Grote, Dongli Zhou, Neru Munshi, Marcis Bajars, and James L. Gulley
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer, Martin H. Voss, Michael S. Gordon, Monica Mita, Brian Rini, Vicky Makker, Teresa Macarulla, David C. Smith, Andrés Cervantes, Igor Puzanov, Roberto Pili, Ding Wang, Shadia Jalal, Shubham Pant, Manish R. Patel, Rachel L. Neuwirth, Aaron Enke, Yaping Shou, Farhad Sedarati, Douglas V. Faller, and Howard A. Burris
Variability in Cytogenetic Testing for Multiple Myeloma: A Comprehensive Analysis From Across the United States, Yang Yu, Niquelle Brown Wade, Amie E. Hwang, Ajay K. Nooka, Mark A. Fiala, Ann Mohrbacher, Edward S. Peters, Karen Pawlish, Cathryn Bock, David J. Van Den Berg, Kristin A. Rand, Daniel Stram, David V. Conti, Daniel Auclair, Graham A. Colditz, Jayesh Mehta, Christopher A. Haiman, Howard Terebelo, Nalini Janakiraman, Seema Singhal, Brian Chiu, Ravi Vij, Leon Bernal-Mizrachi, Jeffrey A. Zonder, Carol A. Huff, Sagar Lonial, Robert Z. Orlowski, Wendy Cozen, and Sikander Ailawadhi
Submissions from 2019
Exploration of the carmaphycins as payloads in antibody drug conjugate anticancer agents, Jehad Almaliti, Bailey Miller, Halina Pietraszkiewicz, Evgenia Glukhov, C B. Naman, Toni Kline, Jeffrey Hanson, Xiaofan Li, Sihong Zhou, Frederick A. Valeriote, and William H. Gerwick
Rates of deep molecular response by digital and conventional PCR with frontline nilotinib in newly diagnosed chronic myeloid leukemia: a landmark analysis, Jesus G. Berdeja, Michael C. Heinrich, Shaker R. Dakhil, Stuart L. Goldberg, Martha Wadleigh, Philip Kuriakose, Jorge Cortes, Jerald Radich, Bret Helton, David Rizzieri, Carole Paley, Ilva Dautaj, and Michael J. Mauro
Highly Convergent Total Synthesis and Assignment of Absolute Configuration of Majusculamide D, a Potent and Selective Cytotoxic Metabolite from Moorea sp, Eduardo JE Caro-Diaz, Frederick A. Valeriote, and William H. Gerwick
A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors, Ezra EW Cohen, Michael J. Pishvaian, Dale R. Shepard, Ding Wang, Jared Weiss, Melissa L. Johnson, Christine H. Chung, Ying Chen, Bo Huang, Craig B. Davis, Francesca Toffalorio, Aron Thall, and Steven F. Powell
The effects of lapatinib on cardiac repolarization: results from a placebo controlled, single sequence, crossover study in patients with advanced solid tumors, Shodeinde A. Coker, Herbert I. Hurwitz, Sunil Sharma, Ding Wang, Pierre Jordaan, Juan P. Zarate, and Lionel D. Lewis
A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105, Alexander Drilon, Siqing Fu, Manish R. Patel, Marwan Fakih, Ding Wang, Anthony J. Olszanski, Daniel Morgensztern, Stephen V. Liu, Byoung C. Cho, Lyudmila Bazhenova, Cristina P. Rodriguez, Robert C. Doebele, Antoinette Wozniak, Karen L. Reckamp, Tara Seery, Petros Nikolinakos, Zheyi Hu, Jennifer W. Oliver, Denise Trone, Katherine McArthur, Rupal Patel, Pratik S. Multani, and Myung-Ju Ahn
Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared With Cytotoxic Chemotherapy, Michael G. Fradley, Matthew Gliksman, Josephine Emole, Federico Viganego, Isaac Rhea, Allan Welter-Frost, Merna Armanious, Dae-Hyun Lee, Christine Walko, Bijal Shah, Julio C. Chavez, Howard McLeod, Javier Pinilla-Ibarz, and Matthew B. Schabath
The KRAS, Jill Hallin, Lars D. Engstrom, Lauren Hargis, Andrew Calinisan, Ruth Aranda, David M. Briere, Niranjan Sudhakar, Vickie Bowcut, Brian R. Baer, Joshua A. Ballard, Michael R. Burkard, Jay B. Fell, John P. Fischer, Guy P. Vigers, Yaohua Xue, Sole Gatto, Julio Fernandez-Banet, Adam Pavlicek, Karen Velastagui, Richard C. Chao, Jeremy Barton, Mariaelena Pierobon, Elisa Baldelli, Emanuel F. Patricoin, Douglas P. Cassidy, Matthew A. Marx, I Rybkin, Melissa L. Johnson, Sai-Hong I. Ou, Piro Lito, Kyriakos P. Papadopoulos, Pasi A. Jänne, Peter Olson, and James G Christensen
A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 Assessment, Meredith C. Henderson, Michael Silver, Quynh Tran, Elias E. Letsios, Rao Mulpuri, David E. Reese, Ana P. Lourenco, Joshua LaBaer, Karen S. Anderson, Josie Alpers, Carrie Costantini, Nitin Rohatgi, Haythem Y. Ali, Karen Baker, Donald W. Northfelt, Karthik Ghosh, Stephen R. Grobmyer, Winnie Polen, and Judith K. Wolf
Evaluation of a Multidisciplinary Team Approach for Generating Survivorship Care Plan Treatment Summaries in Patients With Breast Cancer, Tommy Ivanics, Erica Proctor, Yalei Chen, Haythem Y. Ali, Dawn Severson, Hassan Nasser, Sonja Colbert, Laura L. Susick, Eleanor Walker, Lindsay Petersen, Jessica Bensenhaver, Randa Loutfi, S. David Nathanson, and Lisa A. Newman
Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry, Brittany D. Jenkins, Rachel N. Martini, Rupali Hire, Andrea Brown, Briana Bennett, I'nasia Brown, Elizabeth W. Howerth, Mary Egan, Jamie Hodgson, Clayton Yates, Rick Kittles, Dhananjay A. Chitale, Haythem Y. Ali, S. David Nathanson, Petros Nikolinakos, Lisa A. Newman, Michele Monteil, and Melissa B. Davis
Evaluation of the impact of thyroiditis development in patients receiving immunotherapy with programmed cell death-1 inhibitors, Matthew Lei, Angela Michael, Seema Patel, and Ding Wang
The role of a low erythropoietin level for the polycythemia vera diagnosis, Oleksandra Lupak, Xiaoxia Han, Peter Xie, Sharmeen Mahmood, Hadi Mohammed, and Vijayalakshmi Donthireddy
Class III β-tubulin expression as a predictor of docetaxel-resistance in metastatic castration-resistant prostate cancer, Lucas G. Maahs, Bertha E. Sanchez, Nilesh S. Gupta, Meredith Van Harn, Evelyn R. Barrack, Prem-Veer Reddy, and Clara Hwang
RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer, Daniel Morgensztern, Michal Rose, Saiama N. Waqar, John Morris, Patrick C. Ma, Thomas Reid, Christina E. Brzezniak, Karen G. Zeman, Arvinda Padmanabhan, JoAnn Hirth, Alexander I Spira, Jane B. Trepel, and Sukhmani K. Padda
Hereditary Susceptibility for Triple Negative Breast Cancer Associated With Western Sub-Saharan African Ancestry: Results From an International Surgical Breast Cancer Collaborative, Lisa A Newman, Brittany Jenkins, Yalei Chen, Joseph K Oppong, Ernest Adjei, Aisha S Jibril, Syed Hoda, Esther Cheng, Dhananjay Chitale, Jessica M Bensenhaver, Baffour Awuah, Mahteme Bekele, Engida Abebe, Ishmael Kyei, Frances Aitpillah, Michael Adinku, S. David Nathanson, LaToya Jackson, Evelyn M. Jiagge, Sofia Merajver, Lindsay Petersen, Erica Proctor, Kofi K Gyan, Rachel Martini, Rick Kittles, and Melissa B Davis
Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamide, Amanda B. Pilling and Clara Hwang
Castration-resistant prostate cancer: Androgen receptor inactivation induces telomere DNA damage, and damage response inhibition leads to cell death, Vidyavathi Reddy, Asm Iskander, Clara Hwang, George Divine, Mani Menon, Evelyn R. Barrack, Prem-Veer Reddy, and Sahn-Ho Kim
US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials, Jeanne M. Regnante, Nicole A. Richie, Lola Fashoyin-Aje, Michelle Vichnin, Marvella Ford, Upal B. Roy, Kenneth Turner, Laura L. Hall, Evelyn Gonzalez, Nestor Esnaola, Luther T. Clark, Homer C. Adams, Olatunji B. Alese, Keerthi Gogineni, Lorna McNeill, Daniel Petereit, Ify Sargeant, Julie Dang, Coleman Obasaju, Quita Highsmith, Simon C. Lee, Spencer C. Hoover, Erin L. Williams, and Moon S. Chen
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation, Ayman Saad, Lawrence Lamb, Tao Wang, Michael T. Hemmer, Stephen Spellman, Daniel Couriel, Amin Alousi, Joseph Pidala, Hisham Abdel-Azim, Vaibhav Agrawal, Mahmoud Aljurf, Amer M. Beitinjaneh, Vijaya R. Bhatt, David Buchbinder, Michael Byrne, Jean-Yves Cahn, Mitchell Cairo, Paul Castillo, Saurabh Chhabra, Miguel A. Diaz, Shatha Farhan, Yngvar Floisand, Hadar A. Frangoul, Shahinaz M. Gadalla, James Gajewski, Robert P. Gale, Manish Gandhi, Usama Gergis, Betty K. Hamilton, Peiman Hematti, Gerhard C. Hildebrandt, Rammurti T. Kamble, Abraham S Kanate, Pooja Khandelwal, Aleksandr Lazaryn, Margaret MacMillan, David I Marks, Rodrigo Martino, Parinda A Mehta, Taiga Nishihori, Richard F Olsson, Sagar S Patel, Muna Qayed, Hemalatha G Rangarajan, Ran Reshef, Olle Ringden, Bipin N Savani, Harry C Schouten, Kirk R Schultz, Sachiko Seo, Brian C Shaffer, Melhem Solh, Takanori Teshima, Alvaro Urbano-Ispizua, Leo F Verdonck, Ravi Vij, Edmund K Waller, Basem William, Baldeep Wirk, Jean A Yared, Lolie C Yu, Mukta Arora, and Shahrukh Hashmi
Colorectal Cancer and Nutrition, Kannan Thanikachalam and Gazala Khan
Development of an algorithm for the systematic evaluation of patients with suspected heparin-induced thrombocytopenia, Julie Thomson, Philip Kuriakose, Long To, Michael Peters, and James Kalus
A rare case of follicular lymphoma transformed to a high-grade B-cell lymphoma in orbit, Raju K. Vaddepally, Amal Hejab, Vrushali Dabak, and Madhu P. Menon
Computationally Assisted Discovery and Assignment of a Highly Strained and PANC-1 Selective Alkaloid from Alaska's Deep Ocean, Yike Zou, Xiaojuan Wang, James Sims, Bin Wang, Pankaj Pandey, Colin L. Welsh, Robert P. Stone, Mitchell A. Avery, Robert J. Doerksen, Daneel Ferreira, Clemens Anklin, Frederick A. Valeriote, Michelle Kelly, and Mark T. Hamann
Submissions from 2018
A Lesion on the Scalp, Zaid Abdel-Rahman, Kedar Inamdar, and Haythem Y. Ali
Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis, Sharon H. Alford, George Divine, Chun Chao, Laurel A. Habel, Nalini Janakiraman, Yun Wang, Heather Spencer Feigelson, Delia Scholes, Doug Roblin, Mara M. Epstein, Lawrence Engel, Suzanne Havstad, Karen Wells, Marianne U. Yood, Joan Fortuny, and Christine C. Johnson
Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer, Aditya Bardia, Ayca Gucalp, Noashir DaCosta, Nashat Gabrail, Michael Danso, Haythem Y. Ali, Kimberly L. Blackwell, Lisa A. Carey, Joel R. Eisner, Edwina S. Baskin-Bey, and Tiffany A. Traina
Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer, Jessica L. Christenson, Jane B. Trepel, Haythem Y. Ali, Sunmin Lee, Joel R. Eisner, Edwina S. Baskin-Bey, Anthony D. Elias, and Jennifer K. Richer
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study, S de Vos, L J. Swinnen, Ding Wang, E Reid, N Fowler, J Cordero, M Dunbar, S H. Enschede, C Nolan, A M. Petrich, J A. Ross, A H. Salem, M Verdugo, S Agarwal, L Zhou, M Kozloff, L J. Nastoupil, and C R. Flowers
Unexplained pancytopenia in acute myeloid leukemia treatment, Daniel Ezekwudo, Oleksandra Lupak, Raju Vaddepally, Bolanle Gbadamosi, and Philip Kuriakose
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer, R S. Finn, D H. Ahn, M M. Javle, B R. Tan, C D. Weekes, J C. Bendell, A Patnaik, Gazala Khan, D Laheru, R Chavira, J Christy-Bittel, E Barrett, M B. Sawyer, and Tanios S. Bekaii-Saab
A Retrospective Study Analyzing the Appropriateness of Initial Treatment of, Aaron Fisher, Pradeep Khanal, Ewa Gniado, Leila Khaddour, Molly Orosey, Ismail Hader, Siddhartha Yadav, and Alexandra Halalau
Nab-paclitaxel-based therapy in underserved patient populations: The aboundPs2 study in patients with nsclc and a performance status of 2, Ajeet Gajra, Nagla A. Karim, Deborah A. Mulford, Liza C. Villaruz, Marc R. Matrana, Haythem Y. Ali, Edgardo S. Santos, Tymara Berry, Teng J. Ong, Alexandra Sanford, Katayoun Amiri, and David R. Spigel
Management of haemophilia carriers around the time of their delivery: Phenotypic variation requiring customization of management, M R. Girgis, L Gusba, and Philip Kuriakose
Genitourinary Pathology Reporting Parameters Most Relevant to the Medical Oncologist, Clara Hwang
Enrichment and mutation detection of circulating tumor cells from blood samples, Ruqin Kou, Jian Zhao, Priya Gogoi, Shannon Carskadon, Will Chow, Clara Hwang, Nallasivam Palanisamy, Conrad Leung, and Yixin Wang
Graft-versus-host disease in recipients of male unrelated donor compared with parous female sibling donor transplants, Anita J. Kumar, Soyoung Kim, Michael T. Hemmer, Mukta Arora, Stephen R. Spellman, Joseph A. Pidala, Daniel R. Couriel, Amin M. Alousi, Mahmoud D. Aljurf, Jean-Yves Cahn, Mitchell S. Cairo, Corey S. Cutler, Shatha Farhan, Usama Gergis, Gregory A. Hale, Shahrukh K. Hashmi, Yoshihiro Inamoto, Rammurti T. Kamble, Mohamed A. Kharfan-Dabaja, Margaret L. MacMillan, David I. Marks, Hideki Nakasone, Maxim Norkin, Muna Qayed, Olle Ringden, Harry C. Schouten, Kirk R. Schultz, Melhem M. Solh, Takanori Teshima, Alvaro Urbano-Ispizua, Leo F. Verdonck, Robert P. Gale, Betty K Hamilton, Navneet S Majhail, and Alison W Loren
The potential of achiral sponge-derived and synthetic bromoindoles as selective cytotoxins against PANC-1 tumor cells, Nicholas Lorig-Roach, Frances Hamkins-Indik, Tyler A. Johnson, Karen Tenney, Frederick A. Valeriote, and Phillip Crews
SAPHO Syndrome Masquerading as Metastatic Breast Cancer, Devin Malik, Richa Handa, Andrew Petraszko, and Sheela Tejwani
Normolipemic Xanthomas in a Patient with Underlying Plasma Cell Dyscrasia, Devin Malik, Sukhpreet Singh, and Akshay Amaraneni
Breast cancer metastasis through the lympho-vascular system, S. David Nathanson, David Krag, Henry M. Kuerer, Lisa A. Newman, Markus Brown, Dontscho Kerjaschki, Ethel R. Pereira, and Timothy P. Padera
Utilization of the 21-Gene Recurrence Score in a Diverse Breast Cancer Patient Population: Development of a Clinicopathologic Model to Predict High-Risk Scores and Response to Neoadjuvant Chemotherapy, Ko-Un Park, Yalei Chen, Dhananjay A. Chitale, Sarah Choi, Haythem Y. Ali, S David Nathanson, Jessica Bensenhaver, Erica Proctor, Lindsay Petersen, Randa Loutfi, Alyson Simonds, Marcia Kuklinski, Thomas Doyle, Vrushali Dabak, Kim Cole, Melissa B. Davis, and Lisa A. Newman
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial, Manish R. Patel, John Ellerton, Jeffrey R. Infante, Manish Agrawal, Michael Gordon, Raid Aljumaily, Carolyn D. Britten, Luc Dirix, Keun-Wook Lee, Mathew Taylor, Patrick Schöffski, Ding Wang, Alain Ravaud, Arnold B. Gelb, Junyuan Xiong, Galit Rosen, James L. Gulley, and Andrea B. Apolo
ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer, Amanda B. Pilling, Jihye Kim, Adriana Estrada-Bernal, Qiong Zhou, Anh T. Le, Katherine R. Singleton, Lynn E. Heasley, Aik C. Tan, James DeGregori, and Robert C. Doebele
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours, Eric Raymond, Matthew H. Kulke, Shukui Qin, Xianjun Yu, Michael Schenker, Antonio Cubillo, Wenhui Lou, Jiri Tomasek, Espen Thiis-Evensen, Jian-Ming Xu, Adina E. Croitoru, Mustafa Khasraw, Eva Sedlackova, Ivan Borbath, Paul Ruff, Paul E. Oberstein, Tetsuhide Ito, Liqun Jia, Pascal Hammel, Lin Shen, Shailesh V. Shrikhande, Yali Shen, Jozef Sufliarsky, Gazala Khan, Chigusa Morizane, Salvatore Galdy, Reza Khosravan, Kathrine C. Fernandez, Brad Rosbrook, and Nicola Fazio
A cross-sectional analysis of cardiovascular disease in the hemophilia population, Suman L. Sood, Dunlei Cheng, Margaret Ragni, Craig M. Kessler, Doris Quon, Amy D. Shapiro, Nigel S. Key, Marilyn J. Manco-Johnson, Adam Cuker, Christine Kempton, Tzu-Fei Wang, M E. Eyster, Philip Kuriakose, Annette von Drygalski, Joan C. Gill, Allison Wheeler, Peter Kouides, Miguel A. Escobar, Cindy Leissinger, Sarah Galdzicka, Marshall Corson, Crystal Watson, and Barbara A. Konkle
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer, M L. Telli, D G. Stover, S Loi, S Aparicio, L A. Carey, S M. Domchek, Lisa A. Newman, G W. Sledge, and E P. Winer
Computationally Assisted Assignment of the Kadsuraols, a Class of Chemopreventive Agents for the Control of Liver Cancer, Xiaojuan Wang, Jiabao Liu, Pankaj Pandey, Frank R. Fronczek, Robert J. Doerksen, Jiabao Chen, Xinzhu Qi, Peicheng Zhang, Daneel Ferreira, Frederick A. Valeriote, Hua Sun, Shuai Li, and Mark T. Hamann
nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial, D A. Yardley, R Coleman, P Conte, J Cortes, A Brufsky, M Shtivelband, R Young, C Bengala, Haythem Y. Ali, J Eakel, A Schneeweiss, L de la Cruz-Merino, S Wilks, J O'Shaughnessy, S Glück, H Li, J Miller, D Barton, and N Harbeck
Submissions from 2017
Clinical impact of metformin in diabetic diffuse large B-cell lymphoma patients: a case-control study, Yaser Alkhatib, Zaid Abdel-Rahman, and Philip Kuriakose
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study, Andrea B. Apolo, Jeffrey R. Infante, Ani Balmanoukian, Manish R. Patel, Ding Wang, Karen Kelly, Anthony E. Mega, Carolyn D. Britten, Alain Ravaud, Alain C. Mita, Howard Safran, Thomas E. Stinchcombe, Marko Srdanov, Arnold B. Gelb, Michael Schlichting, Kevin Chin, and James L. Gulley
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor, Johanna C. Bendell, Milind Javle, Tanios S. Bekaii-Saab, Richard S. Finn, Zev A. Wainberg, Daniel A. Laheru, Colin D. Weekes, Benjamin R. Tan, Gazala Khan, Mark M. Zalupski, Jeffrey R. Infante, Suzanne Jones, Kyriakos P. Papadopoulos, Anthony W. Tolcher, Renae E. Chavira, Janna L. Christy-Bittel, Emma Barrett, and Amita Patnaik
Role of Kindness in Cancer Care, Leonard L. Berry, Tracey S. Danaher, Robert A. Chapman, and Rana Awdish
Randomized trial of a question prompt list to increase patient active participation during interactions with black patients and their oncologists, Susan Eggly, Lauren M. Hamel, Tanina S. Foster, Terrance L. Albrecht, Robert Chapman, Felicity WK Harper, Hayley Thompson, Jennifer J. Griggs, Richard Gonzalez, Lisa Berry-Bobovski, Rifky Tkatch, Michael Simon, Anthony Shields, Shirish Gadgeel, Randa Loutfi, Haythem Y. Ali, Ira Wollner, and Louis A. Penner
Chimerism in Myeloid Malignancies following Stem Cell Transplantation Using FluBu4 with and without Busulfan Pharmacokinetics versus BuCy, Shatha Farhan, Michael Bazydlo, Klodiana Neme, Nancy Mikulandric, Edward Peres, and Nalini Janakiraman
TMPRSS2-ERG gene fusion is rare compared to PTEN deletions in stage T1a prostate cancer, Kurt W. Fisher, Shaobo Zhang, Mingsheng Wang, Rodolfo Montironi, Lisha Wang, Lee A. Baldrige, Jonas Y. Wang, Gregory T. MacLennan, Sean R. Williamson, Antonio Lopez-Beltran, and Liang Cheng
Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes, Guillermo Garcia-Manero, Guillermo Montalban-Bravo, Jesus G. Berdeja, Yasmin Abaza, Elias Jabbour, James Essell, Roger M. Lyons, Farhad Ravandi, Michael Maris, Brian Heller, Amy E. DeZern, Sunil Babu, David Wright, Bertrand Anz, Ralph Boccia, Rami S. Komrokji, Philip Kuriakose, James Reeves, Mikkael A. Sekeres, Hagop M. Kantarjian, Richard Ghalie, and Gail J. Roboz
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial, James L. Gulley, Arun Rajan, David R. Spigel, Nicholas Iannotti, Jason Chandler, Deborah JL Wong, Joseph Leach, W J. Edenfield, Ding Wang, Hans J. Grote, Anja von Heydebreck, Kevin Chin, Jean-Marie Cuillerot, and Karen Kelly
Do Patients and Oncologists Discuss the Cost of Cancer Treatment? An Observational Study of Clinical Interactions Between African American Patients and Their Oncologists, Lauren M. Hamel, Louis A. Penner, Susan Eggly, Robert Chapman, Justin F. Klamerus, Michael S. Simon, Sarah CE Stanton, and Terrance L. Albrecht
Associations between use of the 21-gene recurrence score assay and chemotherapy regimen selection in a statewide registry, N L. Henry, Thomas M. Braun, Haythem Y. Ali, Khan Munir, Samuel M. Silver, David H. Gorski, Tara M. Breslin, and Jennifer J. Griggs
Another Look at Pyrroloiminoquinone Alkaloids-Perspectives on Their Therapeutic Potential from Known Structures and Semisynthetic Analogues, Sheng Lin, Erin P. McCauley, Nicholas Lorig-Roach, Karen Tenney, Cassandra N. Naphen, Ai-Mei Yang, Tyler A. Johnson, Thalia Hernadez, Ramandeep Rattan, Frederick A. Valeriote, and Phillip Crews
Renal Complications of Hematopoietic Stem Cell Transplantation: Report of a Case and Review of the Literature, Egbert Liquete, Sean R. Williamson, Nalini Janakiraman, and K. K. Venkat
A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years, Ana P. Lourenco, Kasey L. Benson, Meredith C. Henderson, Michael Silver, Elias Letsios, Quynh Tran, Kelly J. Gordon, Sherri Borman, Christa Corn, Rao Mulpuri, Wendy Smith, Josie Alpers, Carrie Costantini, Nitin Rohatgi, Rebecca Yang, Haythem Y. Ali, Shah Biren, Michael Morris, Fred Kass, and David E. Reese
Investigation of the Physical and Bioactive Properties of Bromo- and Iodo-Containing Sponge-Derived Compounds Possessing an Oxyphenylethanamine Core, Erin P. McCauley, Hanh Lam, Nicholas Lorig-Roach, Justin Luu, Cameron Lloyd, Karen Tenney, Halina Pietraszkiewicz, Cristina Diaz, Frederick A. Valeriote, Victoria Auerbuch, and Phillip Crews
Clues to the Blues: Predictors of Self-Reported Mental and Emotional Health Among Older African American Men, Jamie A. Mitchell, Daphne C. Watkins, Deirdre Shires, Robert A. Chapman, and Janice Burnett
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States, Lori Muffly, Marcelo C. Pasquini, Michael Martens, Ruta Brazauskas, Xiaochun Zhu, Kehinde Adekola, Mahmoud Aljurf, Karen K. Ballen, Ashish Bajel, Frederic Baron, Minoo Battiwalla, Amer Beitinjaneh, Jean-Yves Cahn, Mathew Carabasi, Yi-Bin Chen, Saurabh Chhabra, Stefan Ciurea, Edward Copelan, Anita D'Souza, John Edwards, James Foran, Cesar O. Freytes, Henry C. Fung, Robert P. Gale, Sergio Giralt, Shahrukh K. Hashmi, Gerhard C. Hildebrandt, Vincent Ho, Ann Jakubowski, Hillard Lazarus, Marlise R. Luskin, Rodrigo Martino, Richard Maziarz, Philip McCarthy, Taiga Nishihori, Rebecca Olin, Richard F Olsson, Attaphol Pawarode, Edward Peres, Andrew R Rezvani, David Rizzieri, Bipin N Savani, Harry C Schouten, Mitchell Sabloff, Matthew Seftel, Sachiko Seo, Mohamed L Sorror, Jeff Szer, Baldeep M Wirk, William A Wood, and Andrew Artz
Integrating Molecular Networking and Biological Assays To Target the Isolation of a Cytotoxic Cyclic Octapeptide, Samoamide A, from an American Samoan Marine Cyanobacterium, C B. Naman, Ramandeep Rattan, Svetlana E. Nikoulina, John Lee, Bailey W. Miller, Nathan A. Moss, Lorene Armstrong, Paul D. Boudreau, Hosana M. Debonsi, Frederick A. Valeriote, Pieter C. Dorrestein, and William H. Gerwick
Metastatic Cutaneous Melanoma of the Gallbladder, Dhruvan Patel, Shazia Sohrawardy, Yub R. Sedhai, Soney Basnyat, Anisha Daxini, Aparna Basu, Vivek R. Mehta, Aasim Mohammed, and Steven Lichtenstein
IAP Antagonists Enhance Apoptotic Response to Enzalutamide in Castration-Resistant Prostate Cancer Cells via Autocrine TNF-α Signaling, Amanda B. Pilling, Ok Hwang, Alain Boudreault, Alain Laurent, and Clara Hwang
Cytotoxic halogenated monoterpenes from Plocamium cartilagineum, Omar MM Sabry, Douglas E. Goeger, Frederick A. Valeriote, and William H. Gerwick
Using Speed of Sound Imaging to Characterize Breast Density, Mark Sak, Neb Duric, Peter Littrup, Lisa Bey-Knight, Haythem Y. Ali, Patricia Vallieres, Mark E. Sherman, and Gretchen L. Gierach
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma, M Schlumberger, R Elisei, S Müller, P Schöffski, M Brose, M Shah, L Licitra, J Krajewska, M C. Kreissl, B Niederle, E EW Cohen, L Wirth, Haythem Y. Ali, D O. Clary, Y Yaron, M Mangeshkar, D Ball, B Nelkin, and S Sherman
Combination of Carmustine and Selenite Inhibits EGFR Mediated Growth Signaling in Androgen-Independent Prostate Cancer Cells, Vijayalakshmi Thamilselvan, Mani Menon, Gary S. Stein, Frederick A. Valeriote, and Sivagnanam Thamilselvan
Solitary Skeletal Muscle Metastasis as First Site of Recurrence of Cervical Cancer: A Case Report, Indumathy Varadarajan, Aparna Basu, Sherri Besmer, Jaganmohan Poli, Scott Richard, and Michael Styler
